From: Fauci, Anthony (NIH/NIAID) [E]

Sent: Fri, 21 Feb 2020 13:33:20 +0000

To: Cassetti, Cristina (NIH/NIAID) [E]

Subject: FW: FDA Request

Attachments: FDA Clearance Letter.pdf, Nepal Corona Virus Paper.pdf

Please handle.

Anthony S. Fauci, MD
Director
National Institute of Allergy and Infectious Diseases
Building 31, Room 7A-03
31 Center Drive, MSC 2520
National Institutes of Health
Bethesda, MD 20892-2520
Phone:[ 1 O)@
FAX: (301) 496-4409

Emails Oe
The information in this e-mail and any of its attachments is confidential and may contain sensitive
information. It should not be used by anyone who is not the original intended recipient. If you
have received this e-mail in error please inform the sender and delete it from your mailbox or any
other storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall not
accept liability for any statements made that are the sender's own and not expressly made on
behalf of the NIAID by one of its representatives.

 

From: Jeff Fischerf___ OOF

Sent: Friday, February 21, 2020 8:30 AM

To: Messonnier, Nancy (CDC/DDID/NCIRD/OD) Fi) @)>; Khabbaz, Rima
(CDC/DDID/NCEZID/OD) FO CF >; Fauci, Anthony (NIH/NIAID) (E) FO
Ce: Chris Helm
Subject: FDA Request

 

 

  

Drs Messonnier, Khabbaz, and Fauci,

The Center for Devices and Radiological Health at the FDA suggested that we reach out to cOVID- 19 EUA
developers to |

 

NIH-001689
